Skip to content

Drug interactions

Ribociclib + Rimegepant

Severity: Moderate

Ribociclib and Rimegepant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ribociclib is a moderate CYP3A4 inhibitor and rimegepant is a CYP3A4 substrate, so rimegepant exposure may rise. This raises the potential for increased adverse effects such as nausea and hypersensitivity.

What this interaction means in plain words

Ribociclib and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ribociclib belongs to Oncology; Rimegepant belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated metabolism of rimegepant by ribociclib.

What to do

Avoid taking another rimegepant dose within 48 hours of the previous dose while on ribociclib. Monitor for adverse effects.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ribociclib and Rimegepant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ribociclib with Rimegepant?

MediHelp rates the interaction as moderate. Ribociclib and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ribociclib is a moderate CYP3A4 inhibitor and rimegepant is a CYP3A4 substrate, so rimegepant exposure may rise. This raises the potential for increased adverse effects such as nausea and hypersensitivity.

How serious is the interaction between Ribociclib and Rimegepant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid taking another rimegepant dose within 48 hours of the previous dose while on ribociclib. Monitor for adverse effects.

What other medicines interact with Rimegepant?

MediHelp also lists interactions of Rimegepant with, for example, Amobarbital, Atazanavir, Butabarbital. The full list is on the Rimegepant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in